These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 15010815)
1. Acyclic retinoid in the chemoprevention of hepatocellular carcinoma (review). Kojima S; Okuno M; Matsushima-Nishiwaki R; Friedman SL; Moriwaki H Int J Oncol; 2004 Apr; 24(4):797-805. PubMed ID: 15010815 [TBL] [Abstract][Full Text] [Related]
2. Apoptosis induction by acyclic retinoid: a molecular basis of 'clonal deletion' therapy for hepatocellular carcinoma. Okuno M; Sano T; Matsushima-Nishiwaki R; Adachi S; Akita K; Okano Y; Kojima S; Moriwaki H Jpn J Clin Oncol; 2001 Aug; 31(8):359-62. PubMed ID: 11574627 [TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid. Matsushima-Nishiwaki R; Okuno M; Takano Y; Kojima S; Friedman SL; Moriwaki H Carcinogenesis; 2003 Aug; 24(8):1353-9. PubMed ID: 12807734 [TBL] [Abstract][Full Text] [Related]
4. Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatoma. Moriwaki H; Yasuda I; Shiratori Y; Uematsu T; Okuno M; Muto Y Clin Cancer Res; 1997 May; 3(5):727-31. PubMed ID: 9815742 [TBL] [Abstract][Full Text] [Related]
5. Role of acyclic retinoid in the chemoprevention of hepatocellular carcinoma: basic aspects, clinical applications, and future prospects. Shimizu M; Imai K; Takai K; Moriwaki H Curr Cancer Drug Targets; 2012 Nov; 12(9):1119-28. PubMed ID: 22873214 [TBL] [Abstract][Full Text] [Related]
6. Strategy and mechanism for the prevention of hepatocellular carcinoma: phosphorylated retinoid X receptor alpha is a critical target for hepatocellular carcinoma chemoprevention. Shimizu M; Takai K; Moriwaki H Cancer Sci; 2009 Mar; 100(3):369-74. PubMed ID: 19068086 [TBL] [Abstract][Full Text] [Related]
7. Retinoids in liver fibrosis and cancer. Okuno M; Kojima S; Akita K; Matsushima-Nishiwaki R; Adachi S; Sano T; Takano Y; Takai K; Obora A; Yasuda I; Shiratori Y; Okano Y; Shimada J; Suzuki Y; Muto Y; Moriwaki Y Front Biosci; 2002 Jan; 7():d204-18. PubMed ID: 11779708 [TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of retinoid X receptor alpha at serine 260 impairs its metabolism and function in human hepatocellular carcinoma. Matsushima-Nishiwaki R; Okuno M; Adachi S; Sano T; Akita K; Moriwaki H; Friedman SL; Kojima S Cancer Res; 2001 Oct; 61(20):7675-82. PubMed ID: 11606411 [TBL] [Abstract][Full Text] [Related]
9. [Prevention of recurrent hepatocellular carcinoma with retinoid]. Moriwaki H Gan To Kagaku Ryoho; 2001 Dec; 28(13):1980-4. PubMed ID: 11791378 [TBL] [Abstract][Full Text] [Related]
10. Retinoids in cancer chemoprevention. Okuno M; Kojima S; Matsushima-Nishiwaki R; Tsurumi H; Muto Y; Friedman SL; Moriwaki H Curr Cancer Drug Targets; 2004 May; 4(3):285-98. PubMed ID: 15134535 [TBL] [Abstract][Full Text] [Related]
11. Acyclic retinoid synergises with valproic acid to inhibit growth in human hepatocellular carcinoma cells. Tatebe H; Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Tsurumi H; Moriwaki H Cancer Lett; 2009 Nov; 285(2):210-7. PubMed ID: 19520494 [TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical and nutraceutical approaches for preventing liver carcinogenesis: chemoprevention of hepatocellular carcinoma using acyclic retinoid and branched-chain amino acids. Shimizu M; Shirakami Y; Hanai T; Imai K; Suetsugu A; Takai K; Shiraki M; Moriwaki H Mol Nutr Food Res; 2014 Jan; 58(1):124-35. PubMed ID: 24273224 [TBL] [Abstract][Full Text] [Related]
13. Chemoprevention of hepatocellular carcinoma: concept, progress and perspectives. Okuno M; Kojima S; Moriwaki H J Gastroenterol Hepatol; 2001 Dec; 16(12):1329-35. PubMed ID: 11851828 [TBL] [Abstract][Full Text] [Related]
14. Synergistic growth inhibition of human hepatocellular carcinoma cells by acyclic retinoid and GW4064, a farnesoid X receptor ligand. Ohno T; Shirakami Y; Shimizu M; Kubota M; Sakai H; Yasuda Y; Kochi T; Tsurumi H; Moriwaki H Cancer Lett; 2012 Oct; 323(2):215-22. PubMed ID: 22579649 [TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of hepatocellular carcinoma by acyclic retinoid. Shimizu M; Sakai H; Moriwaki H Front Biosci (Landmark Ed); 2011 Jan; 16(2):759-69. PubMed ID: 21196201 [TBL] [Abstract][Full Text] [Related]
16. Synergistic induction of apoptosis by acyclic retinoid and interferon-beta in human hepatocellular carcinoma cells. Obora A; Shiratori Y; Okuno M; Adachi S; Takano Y; Matsushima-Nishiwaki R; Yasuda I; Yamada Y; Akita K; Sano T; Shimada J; Kojima S; Okano Y; Friedman SL; Moriwaki H Hepatology; 2002 Nov; 36(5):1115-24. PubMed ID: 12395321 [TBL] [Abstract][Full Text] [Related]
17. Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data. Takai K; Okuno M; Yasuda I; Matsushima-Nishiwaki R; Uematsu T; Tsurumi H; Shiratori Y; Muto Y; Moriwaki H Intervirology; 2005; 48(1):39-45. PubMed ID: 15785088 [TBL] [Abstract][Full Text] [Related]
18. Synergistic growth inhibition by 9-cis-retinoic acid plus trastuzumab in human hepatocellular carcinoma cells. Tatebe H; Shimizu M; Shirakami Y; Tsurumi H; Moriwaki H Clin Cancer Res; 2008 May; 14(9):2806-12. PubMed ID: 18451248 [TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of retinoid X receptor suppresses its ubiquitination in human hepatocellular carcinoma. Adachi S; Okuno M; Matsushima-Nishiwaki R; Takano Y; Kojima S; Friedman SL; Moriwaki H; Okano Y Hepatology; 2002 Feb; 35(2):332-40. PubMed ID: 11826406 [TBL] [Abstract][Full Text] [Related]